Bioanalysis of the investigational anti-tumour drug 5,10-dideaza-5,6,7,8-tetrahydrofolic acid by high-performance liquid chromatography with ultraviolet detection

J Chromatogr. 1992 Apr 15;576(1):158-62. doi: 10.1016/0378-4347(92)80188-v.

Abstract

A high-performance liquid chromatographic (HPLC) method with ultraviolet detection at 278 nm is presented for the determination of 5,10-dideaza-5,6,7,8-tetrahydrofolic acid in plasma. Sample pretreatment was achieved by using cation-exchange solid-phase extraction columns with methotrexate as internal standard. Chromatographic separation was based on ion-pair HPLC with 1-octanesulphonic acid as the ion-pairing compound. The detection limit was 10 ng/ml using an 500-microliters sample volume. The assay was linear from the detection limit up to 5000 ng/ml with good reproducibility. The applicability of the assay was demonstrated in a study in the rat.

MeSH terms

  • Animals
  • Antineoplastic Agents / blood*
  • Chromatography, High Pressure Liquid
  • Folic Acid Antagonists / blood*
  • Indicators and Reagents
  • Male
  • Rats
  • Rats, Inbred Strains
  • Spectrophotometry, Ultraviolet
  • Tetrahydrofolates / blood*

Substances

  • Antineoplastic Agents
  • Folic Acid Antagonists
  • Indicators and Reagents
  • Tetrahydrofolates
  • lometrexol